TARA Biosystems Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

TARA Biosystems General Information

Description

Operator of a biotech and an early-stage life-science technology company intended to harness human biology and data to transform cardiac drug discovery by using predictive cardiac tissue models. The company specializes in using stem cells to produce heart cells so that changes in human cardiac function can be measured without human testing, allowing physicians to address heart issues to improve the health and life of their patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 430 East 29th Street
  • Suite 1015
  • New York, NY 10016
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • 430 East 29th Street
  • Suite 1015
  • New York, NY 10016
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TARA Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Apr-2022 Completed Generating Revenue
9. Later Stage VC 17-Nov-2021 Completed Generating Revenue
8. Later Stage VC (Series A2) 23-Jun-2020 Completed Generating Revenue
7. Debt - PPP 11-Apr-2020 Completed Generating Revenue
6. Early Stage VC (Series A) 24-Jan-2018 Completed Generating Revenue
5. Accelerator/Incubator 18-Apr-2017 Completed Startup
4. Seed Round 15-Dec-2015 Completed Startup
3. Accelerator/Incubator 01-Jan-2015 Completed Startup
2. Seed Round 12-Nov-2014 $300K $300K Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view TARA Biosystems’s complete valuation and funding history, request access »

TARA Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A
To view TARA Biosystems’s complete cap table history, request access »

TARA Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech and an early-stage life-science technology company intended to harness human biology and data to t
Drug Discovery
New York, NY
30 As of 2022

Leiden, Netherlands
 

Saint-Sulpice, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TARA Biosystems Competitors (24)

One of TARA Biosystems’s 24 competitors is Ncardia, a Venture Capital-Backed company based in Leiden, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ncardia Venture Capital-Backed Leiden, Netherlands
Nagi Bioscience Venture Capital-Backed Saint-Sulpice, Switzerland
MIMETAS Venture Capital-Backed Oegstgeest, Netherlands
Humacyte Formerly VC-backed Durham, NC
Orgenesis Corporation Germantown, MD
You’re viewing 5 of 24 competitors. Get the full list »

TARA Biosystems Patents

TARA Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021158233-A1 A microphysiological platform with embedded electrodes for 3d tissue culture Inactive 07-Feb-2020
US-12595449-B2 Integrated system for 3d tissue culture Active 07-Feb-2020
US-20230113389-A1 Integrated system for 3d tissue culture Active 07-Feb-2020
WO-2021158598-A1 Integrated system for 3d tissue culture Inactive 07-Feb-2020
CA-2965143-A1 Microfabricated tissue scaffolds and methods of making and using the same Inactive 20-Oct-2014 A61L27/3826
To view TARA Biosystems’s complete patent history, request access »

TARA Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TARA Biosystems Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
180 Degree Capital Hedge Fund Minority
Alexandria Venture Investments Venture Capital Minority
DEFTA Partners Venture Capital Minority
Empire State Development Government Minority
Lifeforce Capital Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

TARA Biosystems FAQs

  • When was TARA Biosystems founded?

    TARA Biosystems was founded in 2014.

  • Where is TARA Biosystems headquartered?

    TARA Biosystems is headquartered in New York, NY.

  • What is the size of TARA Biosystems?

    TARA Biosystems has 30 total employees.

  • What industry is TARA Biosystems in?

    TARA Biosystems’s primary industry is Drug Discovery.

  • Is TARA Biosystems a private or public company?

    TARA Biosystems is a Private company.

  • What is TARA Biosystems’s current revenue?

    The current revenue for TARA Biosystems is .

  • How much funding has TARA Biosystems raised over time?

    TARA Biosystems has raised $29.2M.

  • Who are TARA Biosystems’s investors?

    180 Degree Capital, Alexandria Venture Investments, DEFTA Partners, Empire State Development, and Lifeforce Capital are 5 of 14 investors who have invested in TARA Biosystems.

  • Who are TARA Biosystems’s competitors?

    Ncardia, Nagi Bioscience, MIMETAS, Humacyte, and Orgenesis are some of the 24 competitors of TARA Biosystems.

  • When was TARA Biosystems acquired?

    TARA Biosystems was acquired on 01-Apr-2022.

  • Who acquired TARA Biosystems?

    TARA Biosystems was acquired by Valo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process